[Severe aplastic anemia: indications and limits of biological immunosuppression].
Diagnostic criteria++ and differential therapy of SAA are characterized. A record of ATG/ALG-present modus is demonstrated. The immunosuppressive combination therapy with ALG + Cyclosporin A + MTP represents a prospect.
Exadaktylos
P
P
Klinik und Poliklinik für Kinderheilkunde, Bereich Medizin, Martin-Luther-Universität Halle - Wittenberg.
D000741:Anemia, Aplastic / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents
Schwere aplastische Anämie--Indikationen und Grenzen der biologischen Immunsuppression.